New approaches to rational drug design

被引:17
|
作者
Farber, GK [1 ]
机构
[1] Penn State Univ, Dept Biochem & Mol Biol, Althouse Lab 108, University Pk, PA 16802 USA
关键词
protein crystallography; nonaqueous solvents; organic solvents; co-solvents; structural genomics;
D O I
10.1016/S0163-7258(99)00039-X
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Rational drug design has emerged as a powerful technique. In this review, three new developments in rational drug design are explored. These developments include new methods to find binding sites for small molecules on the surface of a protein, the suggestion that the protein environment may change the shape of a protein sufficiently to alter drug design, and the use of data emerging from structural genomics in drug design. Although these are three new and distinct areas, the insights derived from these studies suggest a reason for the observation that similar drugs do not always bind to a protein in the same manner. (C) 1999 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:327 / 332
页数:6
相关论文
共 50 条
  • [42] New approaches to anticancer drug design based on the inhibition of farnesyltransferase
    Sebti, SM
    Hamilton, AD
    DRUG DISCOVERY TODAY, 1998, 3 (01) : 26 - 33
  • [43] Targeting Cysteine Proteases from Plasmodium falciparum: A General Overview, Rational Drug Design and Computational Approaches for Drug Discovery
    Bekono, Boris D.
    Ntie-Kang, Fidele
    Owono, Luc C. Owono
    Megnassan, Eugene
    CURRENT DRUG TARGETS, 2018, 19 (05) : 501 - 526
  • [44] Synthetically driven rational drug design - Tutorial: MIDAS Technology furthers intelligent drug development without in silico approaches
    Sharma, S
    Spana, C
    GENETIC ENGINEERING NEWS, 2003, 23 (04): : 24 - 24
  • [45] RATIONAL DRUG DESIGN - A MULTIDISCIPLINARY APPROACH
    HUNTER, WN
    MOLECULAR MEDICINE TODAY, 1995, 1 (01): : 31 - 34
  • [46] Bioisosterism: A rational approach in drug design
    Patani, GA
    LaVoie, EJ
    CHEMICAL REVIEWS, 1996, 96 (08) : 3147 - 3176
  • [47] Structural bioinformatics for rational drug design
    Mozaffari, Soroush
    Moen, Agnethe
    Ng, Che Yee
    Nicolaes, Gerry A. F.
    Wichapong, Kanin
    RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2025, 9 (01)
  • [48] DRUG DESIGN - A RATIONAL ATTACK ON INFLUENZA
    TAYLOR, G
    NATURE, 1993, 363 (6428) : 401 - 402
  • [49] LIPIDS, LIPOSOMES, AND RATIONAL DRUG DESIGN
    JANOFF, AS
    LABORATORY INVESTIGATION, 1992, 66 (06) : 655 - 658
  • [50] PHARMACOKINETIC CONSIDERATIONS IN RATIONAL DRUG DESIGN
    GUMBLETON, M
    SNEADER, W
    CLINICAL PHARMACOKINETICS, 1994, 26 (03) : 161 - 168